These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug-Resistant Proteus mirabilis in a University Hospital of Split, Croatia. Rubic Z, Soprek S, Jelic M, Novak A, Goic-Barisic I, Radic M, Tambic-Andrasevic A, Tonkic M. Microb Drug Resist; 2021 Feb; 27(2):162-169. PubMed ID: 32429775 [Abstract] [Full Text] [Related]
5. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF]. Treviño M, Navarro D, Barbeito G, Areses P, García-Riestra C, Regueiro BJ. Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100 [Abstract] [Full Text] [Related]
6. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria. Boudjemaa H, Allem R, Fonkou MDM, Zouagui S, Khennouchi NCEH, Kerkoud M. J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091 [Abstract] [Full Text] [Related]
7. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. Wang JT, Chen PC, Chang SC, Shiau YR, Wang HY, Lai JF, Huang IW, Tan MC, Lauderdale TL, TSAR Hospitals. BMC Infect Dis; 2014 Sep 05; 14():486. PubMed ID: 25192738 [Abstract] [Full Text] [Related]
8. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases]. Rzeczkowska M, Piekarska K, Gierczyński R. Med Dosw Mikrobiol; 2012 Sep 05; 64(4):285-95. PubMed ID: 23484420 [Abstract] [Full Text] [Related]
14. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings. Ibrahimagić A, Bedenić B, Kamberović F, Uzunović S. J Infect Chemother; 2015 May 05; 21(5):363-9. PubMed ID: 25638292 [Abstract] [Full Text] [Related]
17. Dissemination of a Multidrug-Resistant VIM-1- and CMY-99-Producing Proteus mirabilis Clone in Bulgaria. Markovska R, Schneider I, Keuleyan E, Ivanova D, Lesseva M, Stoeva T, Sredkova M, Bauernfeind A, Mitov I. Microb Drug Resist; 2017 Apr 05; 23(3):345-350. PubMed ID: 27341161 [Abstract] [Full Text] [Related]